acetylcysteine has been researched along with Myeloproliferative Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Han, Y; He, X; Hu, X; Kang, H; Liu, S; Liu, Y; Ma, X; Pan, T; Qi, J; Tang, Y; Wu, D; Yao, Y; Zhang, Z; Zhou, M | 1 |
| Brooks, S; Chang, X; Craver, BM; Fleischman, AG; Hoang, S; Lai, HY; Mendez Luque, LF; Ramanathan, G | 1 |
| Droin, N; Lacout, C; Le Couédic, JP; Marty, C; Plo, I; Ribrag, V; Solary, E; Vainchenker, W; Villeval, JL | 1 |
| Qu, CK; Xu, D; Yu, WM; Zheng, H | 1 |
| Bjørn, ME; Hasselbalch, HC | 1 |
| Ghaffari, S; Marinkovic, D; Mungamuri, SK; Sellers, R; Tong, W; Yalcin, S; Zhang, X | 1 |
| Arapakis, G; Gardikas, C; Kirkou, K; Stathakis, N | 1 |
1 review(s) available for acetylcysteine and Myeloproliferative Disorders
| Article | Year |
|---|---|
The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms.
Topics: Acetylcysteine; Animals; Antioxidants; Disease Progression; Hepatitis C; Humans; Inflammation; Mice; Myeloproliferative Disorders; Neoplasms; Oxidative Stress; Primary Myelofibrosis; Reactive Oxygen Species; Signal Transduction | 2015 |
1 trial(s) available for acetylcysteine and Myeloproliferative Disorders
| Article | Year |
|---|---|
Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantation.
Topics: Acetylcysteine; Behavior Therapy; Busulfan; Decitabine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Myeloproliferative Disorders; Neoplasms; Prospective Studies; Reactive Oxygen Species; Transplantation Conditioning | 2023 |
5 other study(ies) available for acetylcysteine and Myeloproliferative Disorders
| Article | Year |
|---|---|
N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm.
Topics: Acetylcysteine; Animals; Humans; Male; Mice; Myeloproliferative Disorders; Thrombosis | 2020 |
A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression.
Topics: Acetylcysteine; Animals; Antioxidants; Blotting, Western; Bone Marrow Transplantation; Case-Control Studies; Disease Progression; DNA Damage; Female; Flow Cytometry; Hematopoietic Stem Cells; Humans; Immunoenzyme Techniques; Janus Kinase 2; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloproliferative Disorders; Point Mutation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2013 |
Activating mutations in protein tyrosine phosphatase Ptpn11 (Shp2) enhance reactive oxygen species production that contributes to myeloproliferative disorder.
Topics: Acetylcysteine; Animals; Bone Marrow Cells; Cell Differentiation; Cytokines; Disease Models, Animal; Hematopoietic Stem Cells; Mice; Mice, Knockout; Mitochondria; Mutation; Myeloid Cells; Myeloproliferative Disorders; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Reactive Oxygen Species; Signal Transduction | 2013 |
ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-/-) mice.
Topics: Acetylcysteine; Adaptor Proteins, Signal Transducing; Animals; Forkhead Box Protein O3; Forkhead Transcription Factors; Free Radical Scavengers; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Knockout; Myeloproliferative Disorders; Proteins; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Splenomegaly; TOR Serine-Threonine Kinases | 2010 |
Lysis of red cells from haematological disorders.
Topics: Acetylcysteine; Acute Disease; Anemia, Aplastic; Erythrocytes; Hemolysis; Histological Techniques; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Myeloproliferative Disorders; Thalassemia | 1972 |